Research ArticleCardiology
Imaging the Cytokine Receptor CXCR4 in Atherosclerotic Plaques with the Radiotracer 68Ga-Pentixafor for PET
Fabien Hyafil, Jaroslav Pelisek, Iina Laitinen, Margret Schottelius, Miriam Mohring, Yvonne Döring, Emiel P.C. van der Vorst, Michael Kallmayer, Katja Steiger, Andreas Poschenrieder, Johannes Notni, Johannes Fischer, Christine Baumgartner, Christoph Rischpler, Stephan G. Nekolla, Christian Weber, Hans-Henning Eckstein, Hans-Jürgen Wester and Markus Schwaiger
Journal of Nuclear Medicine March 2017, 58 (3) 499-506; DOI: https://doi.org/10.2967/jnumed.116.179663
Fabien Hyafil
1Department of Nuclear Medicine, Klinikum Rechts der Isar, Munich, Germany
2Department of Nuclear Medicine, Bichat University Hospital, Assistance Publique–Hôpitaux de Paris, Inserm 1148, DHU FIRE, University Diderot, Paris, France
Jaroslav Pelisek
3Department of Vascular and Endovascular Surgery, Klinikum Rechts der Isar, Munich, Germany
Iina Laitinen
1Department of Nuclear Medicine, Klinikum Rechts der Isar, Munich, Germany
Margret Schottelius
4Pharmaceutical Radiochemistry, Technische Universität München, Garching, Germany
Miriam Mohring
1Department of Nuclear Medicine, Klinikum Rechts der Isar, Munich, Germany
Yvonne Döring
5Institute for Cardiovascular Prevention, Ludwig-Maximilians-Universität München, Munich, Germany
Emiel P.C. van der Vorst
5Institute for Cardiovascular Prevention, Ludwig-Maximilians-Universität München, Munich, Germany
Michael Kallmayer
3Department of Vascular and Endovascular Surgery, Klinikum Rechts der Isar, Munich, Germany
Katja Steiger
6Institute of Pathology, Technische Universität München, Munich, Germany
Andreas Poschenrieder
4Pharmaceutical Radiochemistry, Technische Universität München, Garching, Germany
Johannes Notni
4Pharmaceutical Radiochemistry, Technische Universität München, Garching, Germany
Johannes Fischer
7Centre of Preclinical Research, Klinikum Rechts der Isar, Munich, Germany
Christine Baumgartner
7Centre of Preclinical Research, Klinikum Rechts der Isar, Munich, Germany
Christoph Rischpler
1Department of Nuclear Medicine, Klinikum Rechts der Isar, Munich, Germany
2Department of Nuclear Medicine, Bichat University Hospital, Assistance Publique–Hôpitaux de Paris, Inserm 1148, DHU FIRE, University Diderot, Paris, France
3Department of Vascular and Endovascular Surgery, Klinikum Rechts der Isar, Munich, Germany
4Pharmaceutical Radiochemistry, Technische Universität München, Garching, Germany
5Institute for Cardiovascular Prevention, Ludwig-Maximilians-Universität München, Munich, Germany
6Institute of Pathology, Technische Universität München, Munich, Germany
7Centre of Preclinical Research, Klinikum Rechts der Isar, Munich, Germany
8DZHK (Deutsches Zentrum für Herz-Kreislauf-Forschung e.V.) partner site Munich Heart Alliance, Munich, Germany; and
Stephan G. Nekolla
1Department of Nuclear Medicine, Klinikum Rechts der Isar, Munich, Germany
2Department of Nuclear Medicine, Bichat University Hospital, Assistance Publique–Hôpitaux de Paris, Inserm 1148, DHU FIRE, University Diderot, Paris, France
3Department of Vascular and Endovascular Surgery, Klinikum Rechts der Isar, Munich, Germany
4Pharmaceutical Radiochemistry, Technische Universität München, Garching, Germany
5Institute for Cardiovascular Prevention, Ludwig-Maximilians-Universität München, Munich, Germany
6Institute of Pathology, Technische Universität München, Munich, Germany
7Centre of Preclinical Research, Klinikum Rechts der Isar, Munich, Germany
8DZHK (Deutsches Zentrum für Herz-Kreislauf-Forschung e.V.) partner site Munich Heart Alliance, Munich, Germany; and
Christian Weber
5Institute for Cardiovascular Prevention, Ludwig-Maximilians-Universität München, Munich, Germany
6Institute of Pathology, Technische Universität München, Munich, Germany
7Centre of Preclinical Research, Klinikum Rechts der Isar, Munich, Germany
8DZHK (Deutsches Zentrum für Herz-Kreislauf-Forschung e.V.) partner site Munich Heart Alliance, Munich, Germany; and
9Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, The Netherlands
Hans-Henning Eckstein
3Department of Vascular and Endovascular Surgery, Klinikum Rechts der Isar, Munich, Germany
Hans-Jürgen Wester
4Pharmaceutical Radiochemistry, Technische Universität München, Garching, Germany
Markus Schwaiger
1Department of Nuclear Medicine, Klinikum Rechts der Isar, Munich, Germany
2Department of Nuclear Medicine, Bichat University Hospital, Assistance Publique–Hôpitaux de Paris, Inserm 1148, DHU FIRE, University Diderot, Paris, France
3Department of Vascular and Endovascular Surgery, Klinikum Rechts der Isar, Munich, Germany
4Pharmaceutical Radiochemistry, Technische Universität München, Garching, Germany
5Institute for Cardiovascular Prevention, Ludwig-Maximilians-Universität München, Munich, Germany
6Institute of Pathology, Technische Universität München, Munich, Germany
7Centre of Preclinical Research, Klinikum Rechts der Isar, Munich, Germany
8DZHK (Deutsches Zentrum für Herz-Kreislauf-Forschung e.V.) partner site Munich Heart Alliance, Munich, Germany; and

Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 58, Issue 3
March 1, 2017
Imaging the Cytokine Receptor CXCR4 in Atherosclerotic Plaques with the Radiotracer 68Ga-Pentixafor for PET
Fabien Hyafil, Jaroslav Pelisek, Iina Laitinen, Margret Schottelius, Miriam Mohring, Yvonne Döring, Emiel P.C. van der Vorst, Michael Kallmayer, Katja Steiger, Andreas Poschenrieder, Johannes Notni, Johannes Fischer, Christine Baumgartner, Christoph Rischpler, Stephan G. Nekolla, Christian Weber, Hans-Henning Eckstein, Hans-Jürgen Wester, Markus Schwaiger
Journal of Nuclear Medicine Mar 2017, 58 (3) 499-506; DOI: 10.2967/jnumed.116.179663
Imaging the Cytokine Receptor CXCR4 in Atherosclerotic Plaques with the Radiotracer 68Ga-Pentixafor for PET
Fabien Hyafil, Jaroslav Pelisek, Iina Laitinen, Margret Schottelius, Miriam Mohring, Yvonne Döring, Emiel P.C. van der Vorst, Michael Kallmayer, Katja Steiger, Andreas Poschenrieder, Johannes Notni, Johannes Fischer, Christine Baumgartner, Christoph Rischpler, Stephan G. Nekolla, Christian Weber, Hans-Henning Eckstein, Hans-Jürgen Wester, Markus Schwaiger
Journal of Nuclear Medicine Mar 2017, 58 (3) 499-506; DOI: 10.2967/jnumed.116.179663
Jump to section
Related Articles
Cited By...
- Imaging Inflammation in Atherosclerosis with CXCR4-Directed 68Ga-Pentixafor PET/CT: Correlation with 18F-FDG PET/CT
- CXCR4-binding PET tracers link monocyte recruitment and endothelial injury in murine atherosclerosis
- Modulators of CXCR4 and CXCR7/ACKR3 Function
- Is This Whom We Have Become?
- Anti-Inflammatory Effects on Atherosclerotic Lesions Induced by CXCR4-Directed Endoradiotherapy
- Its the Metabolism That Makes Macrophages Detectable in the Magnetic Resonance Scanner: Immune Cell Detection by Hyperpolarized 13C Magnetic Resonance Imaging
- Clinical Molecular Imaging of Chemokine Receptor CXCR4 Expression in Atherosclerotic Plaque Using 68Ga-Pentixafor PET: Correlation with Cardiovascular Risk Factors and Calcified Plaque Burden
- Integrating MRI and Chemokine Receptor CXCR4-Targeted PET for Detection of Leukocyte Infiltration in Complicated Urinary Tract Infections After Kidney Transplantation
- Unraveling Vascular Inflammation: From Immunology to Imaging
- CXCR4 Ligands: The Next Big Hit?